Medication info
Rovetin Tablet 20 mg (Rosuvastatin Calcium)

Rovetin Tablet 20 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201310590 · Approved 2013.12.09 · Insurance code 642904980

Summary

Main use
Improvement of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular disease risk
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Child dose
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • familial hypercholesterolemia
  • mixed dyslipidemia
  • familial heterozygous hypercholesterolemia
  • dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein levels
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
  • stroke risk
  • myocardial infarction risk
View approved original text

This medication is used as an adjunctive therapy for patients with primary hypercholesterolemia and mixed dyslipidemia when dietary control and exercise alone are inadequate. It is also prescribed as an adjunct to dietary therapy or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This medication lowers total cholesterol and LDL cholesterol levels to target levels, thereby delaying the progression of atherosclerosis, and is particularly effective in adolescents with familial heterozygous hypercholesterolemia. Furthermore, it serves as an adjunctive treatment for patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and revascularization in adults at high risk of cardiovascular disease. Overall, this medication is effectively used to improve lipid abnormalities and prevent cardiovascular diseases.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Child dose

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients with allergies to any of its components, severely impaired liver function, muscle disorders, those taking cyclosporine, patients with severe kidney impairment, pregnant or nursing women, and those at increased risk for muscle-related disorders. This medication should be used with caution in patients who consume excessive alcohol or have a history of liver disease, and regular liver function tests should be conducted before and during treatment. Furthermore, if symptoms such as muscle pain or weakness occur, the healthcare provider should be notified immediately, and the medication may need to be discontinued if necessary. During treatment, rare muscle-related adverse reactions may occur, so symptoms such as muscle pain, weakness, or cramps should be reported immediately. Additionally, high doses may cause kidney function abnormalities, so renal function tests may be necessary. Due to certain genetic factors, the concentration in the body may increase, so dosage adjustments may be needed based on the patient's condition. Serious adverse reactions such as severe skin reactions may occur, so if symptoms such as rash, itching, or swelling arise, the medication should be discontinued immediately and the physician should be consulted. This medication can interact with other drugs, so if there are any other medications being taken, the healthcare provider must be informed. In particular, the risk of muscle adverse reactions may increase when used with certain antiviral agents, immunosuppressants, antibiotics, and fibrates. Women who are pregnant or planning to become pregnant should discuss this medication with their healthcare provider before use and should use appropriate contraception. Nursing women should also avoid this medication. In cases of overdose, since there is no specific antidote, treatment should be based on symptoms, along with liver function and muscle enzyme testing. Caution should be exercised, as dizziness may occur when driving or operating machinery. The drug concentration may be higher in Asians, so this should be considered when determining the dosage.

Side effects

Angioedema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, AST elevation, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain the storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.